An engineered α-1,3-glucanase-derived probe enables sensitive detection of α-1,3-glucan and reveals its soluble release by Aspergillus
α-1,3-Glucan is a major component of the Aspergillus cell wall. However, unlike β-1,3-glucan and galactomannan, α-1,3-glucan was not previously considered to be released in a soluble form. Therefore, its potential as a diagnostic biomarker has remained largely unexplored. In this study, we engineered α-1,3-glucanase mutants to develop α-1,3-glucan-specific binding proteins and detection systems. Mutants derived from the endo-type α-1,3-glucanases, AGN1 and AglKA, were generated, among which AglKA-CatD-D1090A lacked enzymatic activity but retained strong binding affinity for α-1,3-glucan. Using this probe, we established a split luciferase assay to detect α-1,3-glucan in Aspergillus hyphae and conidia without prior purification. Soluble α-1,3-glucan was substantially released by major Aspergillus species, as indicated by results of a sandwich ELISA-like assay with AglKA mutants. These findings suggest that soluble α-1,3-glucan has potential as a complementary diagnostic biomarker for aspergillosis.
Authors
- Ken Miyazawa (ORCID: https://orcid.org/0000-0001-9211-1020)
- Masahiro Kimura (ORCID: https://orcid.org/0000-0002-4611-3364)
- Daisuke Yamanaka (ORCID: https://orcid.org/0000-0002-0046-7052)
- Yoshiyuki Adachi (ORCID: https://orcid.org/0000-0001-7164-6237)
- Kento Suzuki
Institutions
- Tokyo University of Technology (JP)
- Tokyo University of Pharmacy and Life Sciences (JP)
- National Institute of Infectious Diseases (JP)
- Japan Institute for Health Security (JP)
Publication Details
- Journal
- iScience
- Published
- 2026-10-26
- DOI
- https://doi.org/10.1016/j.isci.2026.117952
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science